Wayne Tam

Wayne Tam

Medical Genetics

270-5 76th Avenue
New Hyde Park, NY 11040

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

KRAS-mutated clonal hematopoiesis gives rise to lineage-divergent B-lymphoblastic leukemia/lymphoma and persistent post-therapy monocytosis.

KRAS-mutated clonal hematopoiesis gives rise to lineage-divergent B-lymphoblastic leukemia/lymphoma and persistent post-therapy monocytosis.

Journal: Leukemia & lymphoma

Published: June 21, 2026

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Journal: Human pathology

Published: May 11, 2026

Primary breast follicular lymphoma without a BCL2 rearrangement: insights into extranodal lymphoma biology.

Primary breast follicular lymphoma without a BCL2 rearrangement: insights into extranodal lymphoma biology.

Journal: Blood research

Published: March 29, 2026

Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is Deceptive.

Absent Cyclin D1 Expression in Myeloid Sarcomas Distinguishes From Malignant Histiocytic Neoplasms: When Morphologic Ambiguity is Deceptive.

Journal: The American journal of surgical pathology

Published: March 11, 2026

Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

Journal: Blood advances

Published: January 15, 2026

Concordance Between Fragment Analysis and Next-Generation Sequencing in Identification of Non-Standard CALR Indels.

Concordance Between Fragment Analysis and Next-Generation Sequencing in Identification of Non-Standard CALR Indels.

Journal: International journal of laboratory hematology

Published: September 09, 2025

Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s).

Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s).

Journal: Haematologica

Published: August 20, 2025

MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma.

MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma.

Journal: Blood advances

Published: July 14, 2025

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Journal: Blood advances

Published: July 14, 2025

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.

Journal: Blood advances

Published: July 14, 2025

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Journal: Blood advances

Published: July 08, 2025

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Journal: Blood advances

Published: July 08, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026